| 主权项 |
1. A pharmaceutical composition comprising lithium, wherein the lithium comprises at least 8% 6-Li (e.g., at least 10% 6-Li, at least 20% 6-Li, at least 50% 6-Li, at least 70% 6-Li, at least 80% 6-Li, at least 90% 6-Li, or at least 99% 6-Li); and wherein the composition is formulated for extended release. |
